Coles N Anthony Insider Trades

Insider Trading History

Track insider trading activity for Coles N Anthony. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.23M 1,962 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.52M 1,962 shares
$772.76
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.08M 1,714 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 155 shares
$776.31
$628.73
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
Director
Holding Value $1.23M 1,958 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 1,958 shares
$719.37
$628.73
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $463k 10,290 shares
Last Trade
Aug 01, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$704k 15,638 shares
$45.00
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $97.9M 2,177,417 shares
Last Trade
Jul 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 25,000 shares
$41.35
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $2.29M 50,928 shares
Last Trade
Jul 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 25,000 shares
$41.35
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $1.17M 25,928 shares
Last Trade
Jul 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.03M 25,000 shares
$41.18
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $1.17M 25,928 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$421k 10,290 shares
$40.91
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $2.95M 65,638 shares
Last Trade
Jun 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.03M 50,000 shares
$40.63
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $703k 15,638 shares
Last Trade
Jun 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.03M 50,000 shares
$40.61
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $99M 2,202,417 shares
Last Trade
Jun 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.03M 50,000 shares
$40.63
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $703k 15,638 shares
Last Trade
May 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.11M 50,000 shares
$42.10
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $101M 2,252,417 shares
Last Trade
May 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.11M 50,000 shares
$42.19
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $2.95M 65,638 shares
Last Trade
May 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.11M 50,000 shares
$42.19
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $2.95M 65,638 shares
Last Trade
Apr 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.12M 50,000 shares
$42.32
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $703k 15,638 shares
Last Trade
Apr 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.12M 50,000 shares
$42.33
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $104M 2,302,417 shares
Last Trade
Apr 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.12M 50,000 shares
$42.32
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $703k 15,638 shares
Last Trade
Mar 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.05M 50,000 shares
$41.01
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $106M 2,352,417 shares
Last Trade
Mar 04, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.05M 50,000 shares
$41.09
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $2.95M 65,638 shares
Last Trade
Mar 04, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.05M 50,000 shares
$41.09
$44.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up